SEC Form S-8 filed by REGENXBIO Inc.
As filed with the Securities and Exchange Commission on March 13, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
REGENXBIO Inc.
(Exact name of registrant as specified in its charter)
Delaware |
47-1851754 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
9804 Medical Center Drive Rockville, Maryland 20850 |
|
(Address of Principal Executive Offices and Zip Code) |
2015 Equity Incentive Plan
(Full title of the plans)
Mitchell Chan
Chief Financial Officer
REGENXBIO Inc.
9804 Medical Center Drive
Rockville, Maryland 20850
(Name and address of agent for service)
(240) 552-8181
(Telephone number, including area code, of agent for service)
Copies to:
Kerry Shannon Burke |
Patrick J. Christmas |
Matthew C. Franker |
Chief Legal Officer |
Covington & Burling LLP |
REGENXBIO Inc. |
One CityCenter |
9804 Medical Center Drive |
850 Tenth Street, N.W. |
Rockville, Maryland 20850 |
Washington, D.C. 20001 |
(240) 552-8181 |
(202) 662-6000 |
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b‑2 of the Exchange Act.
Large accelerated filer |
|
Accelerated filer |
|
Non-accelerated filer |
|
Smaller reporting company |
|
|
|
Emerging growth company |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
EXPLANATORY NOTE
This Registration Statement on Form S-8 (the “Registration Statement”) is filed by REGENXBIO Inc. (the “Company”) for the purpose of registering additional shares of its common stock, par value $0.0001 per share (the “Common Stock”), under the Company’s 2015 Equity Incentive Plan (the “Incentive Plan”).
The number of shares of Common Stock available for issuance under the Incentive Plan is subject to an automatic annual increase as of the first business day of the Company’s fiscal year equal to the lower of (a) 4.0% of the total number of shares of Common Stock outstanding on December 31 of the prior year or (b) a number of shares of Common Stock determined by the Company’s Board of Directors (the “Incentive Plan Provision”). Accordingly, the number of shares of Common Stock available for issuance under the Incentive Plan was increased by 1,981,975 shares effective January 2, 2025. This Registration Statement registers the offer and sale of the 1,981,975 additional shares of Common Stock that are available for issuance under the Incentive Plan as a result of the Incentive Plan Provision.
Of the 17,928,064 shares of Common Stock currently authorized by the Incentive Plan, in addition to the shares, the offer and sale of which are being registered hereby, the Company has previously registered the offer and sale of: (a) 2,952,100 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on September 17, 2015 (Commission File No. 333-206984), (b) 1,052,538 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on March 3, 2016 (Commission File No. 333-209899), (c) 1,059,065 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on March 7, 2017 (Commission File No. 333-216508), (d) 1,251,810 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on March 6, 2018 (Commission File No. 333-223466), (e) 1,444,808 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on February 27, 2019 (Commission File No. 333-229910), (f) 1,479,696 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on February 26, 2020 (Commission File No. 333-236664), (g) 1,499,037 shares of Common Stock pursuant to the Company’s Registration Statement on Form S-8 filed on March 1, 2021 (Commission File No. 333-253725), (h) 1,713,246 shares of Common Stock to the Company’s Registration Statement on Form S-8 filed on March 1, 2022 (Commission File No. 333-263182), (i) 1,731,940 shares of Common Stock to the Company’s Registration Statement on Form S-8 filed on February 28, 2023 (Commission File No. 333-270116) and (j) 1,761,849 shares of Common Stock to the Company's Registration Statement on Form S-8 filed on February 27, 2024 (Commission File No. 333-277412) (collectively, the “Original Incentive Plan Registration Statements”).
Pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended, the contents of the Original Incentive Plan Registration Statements, including any amendments thereto or filings incorporated therein by reference are incorporated herein by reference and made part of this Registration Statement. Any items in the Original Incentive Plan Registration Statements not expressly changed hereby shall be as set forth in the Original Incentive Plan Registration Statements.
PART II
Information Required in the Registration Statement
Item 3. Incorporation of Documents by Reference.
The following documents (File No. 001-37553) previously filed with the Securities and Exchange Commission (the “SEC”) are hereby incorporated by reference:
All reports and other documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities registered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents, except as to specific sections of such statements as set forth therein.
Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K (or any portion thereof so furnished) prior or subsequent to the date hereof shall not be incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement.
Item 8. Exhibits.
Exhibit No. |
Description |
4.1* |
|
4.2* |
|
4.3* |
|
4.4* |
|
4.5* |
|
4.6* |
|
5.1 |
|
23.1 |
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm. |
23.2 |
Consent of Covington & Burling LLP (contained in Exhibit 5.1). |
24.1 |
|
107 |
* Incorporated by reference
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rockville, State of Maryland, on this 13th day of March, 2025.
REGENXBIO INC. |
|
|
|
By: |
/s/ Curran Simpson |
|
Curran Simpson |
|
President and Chief Executive Officer |
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Kenneth T. Mills and Patrick J. Christmas, and each of them, as his or her true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8 (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature |
Title |
Date |
/s/ Curran Simpson Curran Simpson
|
President, Chief Executive Officer and Director (Principal Executive Officer) |
March 13, 2025 |
/s/ Mitchell Chan Mitchell Chan
|
Chief Financial Officer (Principal Financial and Accounting Officer) |
March 13, 2025 |
/s/ Kenneth T. Mills Kenneth T. Mills
|
Chairman of the Board of Directors |
March 13, 2025 |
/s/ Jean Bennett Jean Bennett
|
Director |
March 13, 2025 |
/s/ Allan M. Fox |
Director |
March 13, 2025 |
Allan M. Fox
|
||
/s/ Alexandra Glucksmann Alexandra Glucksmann
|
Director |
March 13, 2025 |
/s/ A.N. “Jerry” Karabelas A.N. “Jerry” Karabelas
|
Director |
March 13, 2025 |
/s/ George Migausky George Migausky
|
Director |
March 13, 2025 |
/s/ David C. Stump David C. Stump
|
Director |
March 13 2025 |
/s/ Daniel Tassé Daniel Tassé |
Director |
March 13, 2025 |
/s/ Jennifer Zachary |
Director |
March 13, 2025 |
Jennifer Zachary |
|
|